My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 281

    1.

    Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.

    Ekström K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P.

    Diabetes Care. 2007 Jun;30(6):1357-63. Epub 2007 Mar 19.PMID: 17372150 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

    Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.

    Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46.PMID: 10209561 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.

    Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA.

    J Clin Endocrinol Metab. 1995 Apr;80(4):1312-7.PMID: 7536205 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment with insulin glargine does not suppress serum IGF-1.

    Slawik M, Schories M, Busse Grawitz A, Reincke M, Petersen KG.

    Diabet Med. 2006 Jul;23(7):814-7.PMID: 16842489 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.

    Clark PA, Clarke WL, Pedadda S, Reiss A, Langlois C, Nieves-Rivera F, Rogol AD.

    J Pediatr Endocrinol Metab. 1998;11(3):427-35.PMID: 11517959 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy]

    Peczyńska J, Urban M, Głowińska B, Urban B.

    Pol Merkur Lekarski. 2003 Apr;14(82):336-9. Polish. PMID: 12868196 [PubMed - indexed for MEDLINE]Related articles

    7.

    Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.

    Clayton KL, Holly JM, Carlsson LM, Jones J, Cheetham TD, Taylor AM, Dunger DB.

    Clin Endocrinol (Oxf). 1994 Oct;41(4):517-24.PMID: 7955462 [PubMed - indexed for MEDLINE]Related articles

    8.

    Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.

    Bereket A, Lang CH, Wilson TA.

    Horm Metab Res. 1999 Feb-Mar;31(2-3):172-81. Review.PMID: 10226799 [PubMed - indexed for MEDLINE]Related articles

    9.

    Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

    Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P Jr.

    J Clin Endocrinol Metab. 1997 Apr;82(4):1181-7.PMID: 9100593 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.

    Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebaek NE.

    Clin Endocrinol (Oxf). 1996 May;44(5):515-23.PMID: 8762727 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.

    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.

    J Pediatr Endocrinol Metab. 2004 May;17(5):749-57.PMID: 15237710 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.

    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.

    Am J Physiol Endocrinol Metab. 2006 May;290(5):E1006-13. Epub 2006 Jan 3.PMID: 16390864 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM.

    Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chalé JJ, Rosenfeld R, Tauber JP.

    Diabetologia. 1996 Dec;39(12):1498-504.PMID: 8960832 [PubMed - indexed for MEDLINE]Related articles

    14.

    Derangements of the somatotropic hormone axis in chronic renal failure.

    Tönshoff B, Blum WF, Mehls O.

    Kidney Int Suppl. 1997 Mar;58:S106-13. Review.PMID: 9067957 [PubMed - indexed for MEDLINE]Related articles

    15.

    Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.

    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.

    Clin Endocrinol (Oxf). 2006 Oct;65(4):439-45.PMID: 16984235 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.

    Salgado LR, Semer M, Nery M, Knoepfelmacher M, Lerário AC, Póvoa G, Jana S, Villares SM, Wajchenberg BL, Liberman B, Nicolau W.

    J Endocrinol Invest. 1996 Jul-Aug;19(7):433-40.PMID: 8884537 [PubMed - indexed for MEDLINE]Related articles

    17.

    Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.

    Hedman CA, Frystyk J, Lindström T, Chen JW, Flyvbjerg A, Ørskov H, Arnqvist HJ.

    J Clin Endocrinol Metab. 2004 Dec;89(12):6305-9.PMID: 15579794 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.

    Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM, Dunger DB.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3686-91.PMID: 11502796 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.

    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.

    Clin Endocrinol (Oxf). 2006 Sep;65(3):310-9.PMID: 16918949 [PubMed - indexed for MEDLINE]Related articles

    20.

    The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.

    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.

    Growth Horm IGF Res. 2005 Aug;15(4):304-10.PMID: 16054412 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity